Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
26
pubmed:dateCreated
2005-6-27
pubmed:abstractText
Nitrophorin 2 (NP2) is a salivary lipocalin from Rhodnius prolixus that binds with coagulation factors IX (fIX) and IXa (fIXa). Binding of NP2 with fIXa results in potent inhibition of the intrinsic factor Xase complex. A panel of site-directed surface mutants of NP2 was generated to locate determinants of high affinity fIX(a) binding. The locations of the mutations were based on comparisons with the related, but less potent, inhibitor nitrophorin 3 (NP3). Three point mutants (K21A, K92A, and V94A) were found that clearly reduced the inhibitory potency as measured by the activity of a reconstituted factor Xase system. Binding of NP2 with fIXa and fIX as measured by surface plasmon resonance and isothermal titration calorimetry was reduced in a similar manner. Of the three mutants, two (K92A and V94A) were located on the loop connecting beta-strands E and F of the lipocalin beta-barrel. The largest changes were seen with the K92A mutation, which lies at the apex of the loop, with a smaller effect being seen with mutation of Val(94). Combination of four E-F loop mutations (K92A, A93K, V94A, E97A) in a single mutant reduced the inhibitory potency and binding to levels similar to those seen with NP3 without affecting heme or histamine binding.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
280
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
25022-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:15866866-Amino Acid Sequence, pubmed-meshheading:15866866-Animals, pubmed-meshheading:15866866-Calorimetry, pubmed-meshheading:15866866-Carrier Proteins, pubmed-meshheading:15866866-Cell Membrane, pubmed-meshheading:15866866-Dose-Response Relationship, Drug, pubmed-meshheading:15866866-Factor IX, pubmed-meshheading:15866866-Factor IXa, pubmed-meshheading:15866866-Heme, pubmed-meshheading:15866866-Hemeproteins, pubmed-meshheading:15866866-Histamine, pubmed-meshheading:15866866-Humans, pubmed-meshheading:15866866-Inhibitory Concentration 50, pubmed-meshheading:15866866-Kinetics, pubmed-meshheading:15866866-Lipocalin 1, pubmed-meshheading:15866866-Models, Chemical, pubmed-meshheading:15866866-Models, Molecular, pubmed-meshheading:15866866-Molecular Sequence Data, pubmed-meshheading:15866866-Mutagenesis, Site-Directed, pubmed-meshheading:15866866-Mutation, pubmed-meshheading:15866866-Point Mutation, pubmed-meshheading:15866866-Protein Binding, pubmed-meshheading:15866866-Rhodnius, pubmed-meshheading:15866866-Salivary Proteins and Peptides, pubmed-meshheading:15866866-Sequence Homology, Amino Acid, pubmed-meshheading:15866866-Surface Plasmon Resonance, pubmed-meshheading:15866866-Time Factors
pubmed:year
2005
pubmed:articleTitle
Structural determinants of factor IX(a) binding in nitrophorin 2, a lipocalin inhibitor of the intrinsic coagulation pathway.
pubmed:affiliation
Laboratory of Malaria and Vector Research NIAID, National Institutes of Health, Bethesda, Maryland 20892, USA.
pubmed:publicationType
Journal Article